lab-on-a-chip market By Product (Reagents & Consumables, Software, IV Needles), By Technology (Microarrays, Microfluidics, Tissue Biochip, Others), By Application (Genomics, Proteomics, Point of Care Diagnostics, Drug Discovery, Others), By End-Use (Hospitals and Clinics, Biotechnology and Pharmaceuticals Companies, Forensic Laboratories, Diagnostics Centers), and Region, Global Forecast 2020 to 2030.

The global lab-on-a-chip market is expected to develop USD 15 billion by 2030, at a compound annual increase in price (CAGR) of 11.24% throughout the forecast period.

The development of a miniaturized device called lab-on-a-chip (LOC) is the among the latest advancements in the field of nanotechnology. Lab-on-a-chip is a miniaturized device that integrates fluidics, electronics, optics and bio-sensors functions on a chip size ranging from a few millimeters to a few square centimeters. Analyses such as biochemical detection or DNA sequencing are done efficiently on lab-on-a-chip. This device helps to attain high-throughput screening and automation. Lab-on-a-chip research majorly focuses on human diagnostics and DNA analysis than the synthesis of chemicals. The laboratory-on-a-chip technology is expected to enable highly complex laboratory testing to move from the central laboratory into non-laboratory settings. The development of the lab-on-a-chip field mainly depends on two technologies such as microfluidics and molecular biology.

In the field of proteomics and genomics, lab-on-a-chip technology provides the opportunity to perform protein analysis by accumulating all the steps such as extraction from the cell, separation by electrophoresis, digestion, and analysis using mass spectrometry within the same chip. Lab-on-a-chip also has potential in analysing protein crystallization. In order to speed up the discovery of crystallization conditions for unknown proteins and study their structures using X-ray diffraction, the most important factor is the ability to parallelize crystallization conditions. In cancer research, separation of tumor cells from normal counterpart without using monoclonal antibodies and phenotyping characterization of tumor cells, isolation of cells present in very low concentration within heterogeneous cell populations are done using dielectrophoresis (DEP)-based lab-on-a-chip.

The application of lab-on-a-chip is growing in different areas of life sciences such as from detecting breast cancer to screening for HIV, surviving the serious disease, all of it is done with the help of a chip or a microarray. Lab-on-a-chip technology uses small fluid volumes which helps in cutting costs and analysis of reagents and response time and the emergence of this technology is highly compact systems through mass production. Presently, the roles and applications of LOC in the healthcare system helps in the early detection of outbreak diseases such as ebola and zika. Rising adoption of personalized medicine, regulatory approval for personalized medicine and increased commercial application of biochips are anticipated to drive the lab-on-a-chip market. However, limited technological knowledge and availability of alternative technologies are anticipated to restrict the market growth.

Diagnostics segment is expected to account for significant revenue share in the global market

Application of lab-on-a-chip technology in diagnostics is expected to account for prominent revenue share due to the growing demand for high speed, efficiency, and sensitivity of results. The rising global population eventually increases the number of patients with diseases and subsequently shall augment the demand for microfluidic systems for diagnosis, treatment, and monitoring of these diseases. The use of lab-on-a-chip technology is further increasing due to the growth in adoption of personalized medicine, drug discovery and life science research, and growing need for high speed diagnostics.

North America and Asia Pacific are anticipated to account for significant revenue share in the global market

North America is estimated to account for significant market share due to high demand for microfluidic products in the diagnostics, pharma and clinical sectors for its widening usage and proven cost effectiveness in various applications. Presence of sophisticated healthcare system is another driver for the significant growth of lab-on-a-chip market in this region. Lab-on-a-chip market is experiencing lucrative growth in Asia Pacific pertaining to the growing population and popularity of conventional biological laboratories in this region. High concentration of CRO activities in the region is also a key factor supporting swift market growth in Asia Pacific.

Key Market Players

• Agilent Technologies, Inc
• Danaher Corporation
• Becton, Dickinson and Company
• Bio-Rad Laboratories
• Abbott Laboratories
• F. Hoffmann-La Roche Ag
• Perkinelmer, Inc
• IDEX Corporation
• Thermo Fisher Scientific, Inc
• Raindance Technologies, Inc
• Fluidigm Corporation
• Others

lab-on-a-chip market Scope

Market Segments: Lab-on-a-chip Market

By Product

• Reagents & Consumables
• Instruments
• Software & Services

By Technology

• Microarray
• Microfluidics
• Tissue Biochip
• Others

By Application

• Genomics & Proteomics
• Diagnostics
• Others

By End User

• Hospitals & Clinics
• Diagnostic Centers
• Academic & Research Institutes
• Others

By Region

North America

• US
• Canada

Europe

• Germany
• France
• UK

Asia Pacific

• China
• India
• Japan

Middle East & Africa

• UAE
• South Africa

Central & South America

• Brazil
• Mexico